Dr. Razan Jammal
Global Product Manager, Pall Corporation
Dr. Razan Jammal joined Pall in January 2020 to manage the filter integrity and leak test instruments portfolio. Previously, she worked as EMEA product marketing manager for instrumentation and clinical application technology in the IVD market. Razan has a Masters’ degree in Genetic engineering and holds a PhD degree in Oncology from Hannover Medical School.
Dr. Jörg Schubert
Director Aseptic and Virus Consultants, Pall Corporation
Dr. Jörg Schubert has more than 24 years of combined experience in technical support, process optimization, filter validation and R&D. He has an extensive experience with DSP applications including direct flow filtration technology (sterile, depth & virus filtration), comprehensive expertise in single-use systems and over 20 years of experience in filter integrity testing in the pharmaceutical and biotech industry. Jörg Schubert has a Masters’ degree in Chemistry, and hold a PhD degree in Technical Chemistry from the Leibniz University Hanover.
Why the introduction of X-ray sterilization technology is a critical change for single-use industry, and how gamma and X-ray irradiation compare
The market demand for gamma irradiation, the current primary method for the sterilization in SUT, will soon significantly exceed supply, creating an urgent need for alternatives.
Join Christelle Marcoux from GSK Vaccines (BioPhorum workstream member on alternatives to gamma sterilization) and James Hathcock, PhD of Pall Corporation (Bio-Process Systems Alliance X-Ray Committee Co-Chair) as they discuss the introduction of X-ray sterilization technology.
You will learn more about:
- Why this is a critical change for industry and the responsibilities of each stakeholder
- Key questions to address for biomanufacturers
- How gamma and X-ray irradiation compare
- What testing has been completed and key milestones for readiness for industry
- An example of how to qualify a SUS sterilized with X-ray irradiation